Insider buying
~$143K70K sh @ $2.05
Traded Nov 3 · filed 10 days later
A Xbiotech director paid $143K out of pocket for Xbiotech shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 26, 2026 · Filed Oct 28, 2026
A Xbiotech director paid $711K out of pocket for Xbiotech shares. Shares held went up 10% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$711,251
Shares × reported transaction price
$500K–$1M
+9.6%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $1.85 on Oct 26, 2026, at its 52-week low, after a 15% drop over the previous 30 trading days
52-week range $1.85 (Oct 26, 2026) to $2.94 (Nov 11, 2025), 0% of the way up, from 251 adjusted closes. 30 trading days earlier: $2.17 on Sep 14, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any XBIT insider since Jun 2019. John Simard's first open-market purchase of XBIT in filings since 2015
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.6% | −4.7% | +1.1% |
Past results only. Not a forecast.
Insider buying
Traded Nov 3 · filed 10 days later
A Xbiotech director paid $143K out of pocket for Xbiotech shares.
Insider filing
Traded Oct 26 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.